Kapadiya, Khushal M.; Khunt, Ranjan C. published the article 《Discovery of Hybrid Purine-quinoline Molecules and Their Cytotoxic Evaluation》. Keywords: purine quinoline hybrid mol NSCLC cytotoxicity.They researched the compound: 2,6-Dichloropurine( cas:5451-40-1 ).COA of Formula: C5H2Cl2N4. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:5451-40-1) here.
Apart from the “”hit drugs””, there are many others being studied for their potent activity against several hostilities. To date, anticancer research has been exploited on the inherent versatility and active core skeleton of the compounds Literature suggests that nitrogen rich mols. are most active and found in their potent cancer activity. Purine-based compounds such as olomoucine and roscovitine, which contain other heterobicyclic ring systems, are useful for the cell proliferation inhibitors in the treatment of many types of cancer. We put forward the novel purine based compounds, aryl amino-quinoline-purine by a two-step procedure. In the first step, nitrogen rich mol. was synthesized by the coupling of 2,6- dichloropurine with 3-aminoquinoline in an acidic reaction conditions at the C-6 position of purine. Aryl amines were introduced at the C-2 position by acid catalyst and using polar solvent at comparatively higher reaction conditions to furnish the desired products. Stereochem. aspect was introduced for the identification of attachment of 3-aminoquinoline at the C-2/C-6 position of purine and it was concluded by the spectral anal. (HMBC spectrum). The spectral data revealed that the first chloro-amine coupling was directed at the C-6 position rather than C-2 and the second chloro-amine coupling by various aryl amines were directed at the C-2 position. The applications of synthesized compounds were identified by their cytotoxic study against NCI-60 cell-lines. Out of nine selected mols. by NCI, 5a has shown promising response in a single dose study and GI50 value, 7.57μM indicated that it has 7.57% lethality over HOP-92 cell-line (non-small cell lung cancer panel). Two straightforward novelties were introduced, first stereochem. identification for chloro-amine coupling in purine either at the C-2 or C-6 position on the basis of HMBC spectrum. And a second type of uniqueness was to identify better anti-cancer agents out of synthesized scaffolds. Overall study shows that compound 5a is a novel therapeutic agent after modification for the treatment of non-small cell lung and it satisfied determined threshold growth inhibition criteria at a single dose level.
I hope my short article helps more people learn about this compound(2,6-Dichloropurine)COA of Formula: C5H2Cl2N4. Apart from the compound(5451-40-1), you can read my other articles to know other related compounds.
Reference:
Oxazolidine – Wikipedia,
Oxazolidine | C3H7NO – PubChem